Table 1.

Characteristics of the subjects with FL or SLL from Study 101-09

FL (n = 72)SLL (n = 26)
Median age (range), y62 (33–84)65 (50–87)
Gender
 Male39 (54%)19 (73%)
 Female33 (46%)7 (27%)
Race
 Caucasian64 (89%)21 (81%)
 African American02 (8%)
 Other8 (11%)3 (11%)
Prior therapies, median (range)4 (2–12)4 (2–9)
LDH > ULN21 (29%)13 (50%)
B-symptoms present11 (15%)5 (19%)
ECOG performance score
 0—166 (92%)25 (96%)
 26 (8%)1 (4%)

Abbreviations: ECOG; Eastern Cooperative Oncology Group; LDH, lactic dehydrogenase; ULN, upper limit of normal.